to determine the mechanism for the decrease of somatomedin levels in insulin-dependent diabetes , the relationships among plasma immunoreactive somatomedin-c ( sm-c ) , plasma growth hormone ( gh ) and prolactin ( prl ) , and the somatogenic and lactogenic binding sites in liver were assessed in rats with nonketotic diabetes mellitus of different duration ( 1 wk or 1 mo ) and severity ( 50 or 60 mg streptozotocin/kg bw ) .
C0037657
somatomedin
C0021665
somatomedin-c